Physician

Mark Jay Stewart, M.D.

According to 2025 Medicare claims, Mark Stewart, M.D. (NPI: 1225114051) practices interventional pain management (ipm) in the Augusta-Richmond County, GA-SC market, with the plurality of this provider's patient population coming from Aiken, SC. This provider's primary affiliated billing organization is THE INTERVENTIONAL SPINE AND PAIN MANAGEMENT CENTER, PC (NPI: 1518012004; TIN: 205507145) and primary practice location at 30909-4583. Stewart is affiliated with the Aledade A3047 MS MSSP Enhanced (ACO ID: A3047) and Southeastern Health Partners (ACO ID: A3325), participating under the MSSP model.

Stewart's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 970 traditional Medicare patients, billed 8,627 HCPCS/CPT codes, and received $604,318 in Medicare payments. The top billing code was G0482 (Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms). Part D data shows 10,954 prescription claims across 977 beneficiaries totaling $461,181 in drug costs, led by Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen). 2015 DME data shows 12 claims. Open Payments data shows 18 records totaling $455. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $361,656 to $604,318. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	749	7,064	$361,656
2016	924	7,636	$399,393
2017	1,050	9,321	$505,521
2018	1,033	8,410	$478,961
2019	1,016	7,268	$448,579
2020	850	4,263	$275,902
2021	704	7,220	$606,601
2022	933	8,395	$650,037
2023	936	8,267	$608,261
2024	970	8,627	$604,318

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	752	7,042	$564,646
2016	909	8,510	$623,233
2017	1,049	9,192	$669,325
2018	1,024	9,030	$715,237
2019	1,063	9,028	$684,532
2020	926	6,922	$441,416
2021	736	8,254	$519,069
2022	890	9,588	$543,722
2023	922	10,441	$516,930
2024	977	10,954	$461,181

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	12	$1,312
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms	249	434	$193
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	565	1,164	$88
80307	Testing for presence of drug, by chemistry analyzers	471	1,276	$61
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	690	1,263	$60
96136	Administration of psychological or neuropsychological test, first 30 minutes	383	455	$31

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	2,266	64,524	$74,991
Percocet	Oxycodone Hcl/Acetaminophen	12	360	$51,783
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	1,625	45,571	$38,111
Xtampza Er	Oxycodone Myristate	118	3,530	$29,962
Hysingla Er	Hydrocodone Bitartrate	57	1,684	$25,282

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	18	$455	Forte Bio-Pharma LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mark Jay Stewart, M.D.?

Tedicare shows public-source Medicare data for Mark Jay Stewart, M.D. (NPI 1225114051), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark Jay Stewart, M.D. have ACO affiliation data?

Mark Jay Stewart, M.D. is shown with ACO affiliation data for Aledade A3047 MS MSSP Enhanced (MSSP, ACO ID A3047) and Southeastern Health Partners (MSSP, ACO ID A3325).

What billing organization is linked to Mark Jay Stewart, M.D.?

Mark Jay Stewart, M.D. is linked to THE INTERVENTIONAL SPINE AND PAIN MANAGEMENT CENTER, PC (billing NPI 1518012004) in the available physician profile data.

Does Mark Jay Stewart, M.D. have Open Payments data?

Mark Jay Stewart, M.D. has 18 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.